Surgery Partners, Inc. (NASDAQ:SGRY) Stock Rated "Hold" by Sell-Side Brokerages

Key Points

• Analysts’ consensus is “Hold”: Of 12 firms covering Surgery Partners, nine rate it Hold, two Buy and one Sell. The average 12-month price target is $20.70.
• The company reported quarterly EPS of $0.16, beating the $0.11 consensus estimate, while revenue of $815.3 million fell short of expectations and was down 0.8% year over year.
• Shares traded at $26.95, near their 12-month high of $27.23. Director Teresa DeLuca also bought 10,000 shares for $143,500 in August.

Shares of Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) have been given a consensus recommendation of "Hold" by the twelve ratings firms that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $20.70.

Several equities analysts recently weighed in on the company. Benchmark reiterated a "buy" rating on shares of Surgery Partners in a research report on Tuesday, August 11th. Royal Bank Of Canada lifted their price target on Surgery Partners from $23.50 to $25.00 and gave the company a "sector perform" rating in a report on Tuesday, November 10th. UBS Group downgraded shares of Surgery Partners from a "buy" rating to a "hold" rating and upped their price objective for the company from $21.00 to $23.50 in a research note on Wednesday, October 28th. Stonex Financial lowered shares of Surgery Partners from a "strong-buy" rating to a "hold" rating in a report on Tuesday, October 27th. Finally, JPMorgan Chase & Co. raised their target price on shares of Surgery Partners from $14.00 to $15.00 and gave the stock a "neutral" rating in a research report on Monday, September 14th.

Insider Buying and Selling

In related news, Director Teresa DeLuca purchased 10,000 shares of the business's stock in a transaction on Tuesday, August 18th. The shares were bought at an average price of $14.35 per share, with a total value of $143,500.00. Following the completion of the purchase, the director directly owned 66,843 shares in the company, valued at approximately $959,197.05. This trade represents a 17.59% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 2.00% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the company. Jupiter Topco LLC acquired a new stake in Surgery Partners in the 2nd quarter valued at $233,220,000. Pentwater Capital Management LP acquired a new position in shares of Surgery Partners during the second quarter worth about $195,384,000. BlackRock Inc. acquired a new position in shares of Surgery Partners during the second quarter worth about $104,857,000. Hsbc Holdings PLC purchased a new stake in shares of Surgery Partners in the second quarter worth about $48,912,000. Finally, Bank of America Corp DE purchased a new stake in shares of Surgery Partners in the second quarter worth about $20,374,000.

Surgery Partners Trading Up 1.4%

SGRY traded up $0.37 during trading on Friday, hitting $26.95. The company's stock had a trading volume of 3,138,836 shares, compared to its average volume of 7,585,225. The firm's 50 day moving average price is $17.30 and its 200-day moving average price is $15.10. The company has a debt-to-equity ratio of 1.03, a current ratio of 2.17 and a quick ratio of 1.78. The stock has a market cap of $3.53 billion, a PE ratio of -39.63 and a beta of 1.85. Surgery Partners has a twelve month low of $11.41 and a twelve month high of $27.23.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings data on Monday, November 9th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.05. The business had revenue of $815.30 million for the quarter, compared to analysts' expectations of $820.96 million. Surgery Partners had a positive return on equity of 0.98% and a negative net margin of 2.59%. The business's revenue was down .8% on a year-over-year basis. During the same quarter last year, the firm earned $0.13 earnings per share. On average, analysts expect that Surgery Partners will post 0.07 earnings per share for the current year.

About Surgery Partners

Surgery Partners, Inc. is a U.S. healthcare services company that owns and operates ambulatory surgery centers and surgical hospitals. Its facilities provide outpatient and inpatient surgical care across a range of specialties. The company's services include surgical procedures and related care delivered in partnership with physicians and healthcare professionals. Its network serves patients in multiple states across the United States. Founded in 2004, Surgery Partners has expanded its network through acquisitions and partnerships with physicians and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.